Leuthold Group LLC acquired a new position in shares of Select Medical Holdings Corporation (NYSE:SEM – Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 31,264 shares of the health services provider’s stock, valued at approximately $464,000.
Several other hedge funds have also recently bought and sold shares of the business. Dana Investment Advisors Inc. raised its holdings in Select Medical by 29.3% in the fourth quarter. Dana Investment Advisors Inc. now owns 678,545 shares of the health services provider’s stock valued at $10,076,000 after buying an additional 153,924 shares during the period. Denali Advisors LLC purchased a new position in Select Medical in the fourth quarter valued at approximately $3,907,000. Western Standard LLC raised its holdings in Select Medical by 95.6% in the fourth quarter. Western Standard LLC now owns 2,064,021 shares of the health services provider’s stock valued at $30,651,000 after buying an additional 1,008,664 shares during the period. Sageworth Trust Co raised its holdings in Select Medical by 33.0% in the fourth quarter. Sageworth Trust Co now owns 39,231 shares of the health services provider’s stock valued at $583,000 after buying an additional 9,744 shares during the period. Finally, Horizon Investments LLC purchased a new position in Select Medical in the fourth quarter valued at approximately $608,000. Hedge funds and other institutional investors own 89.48% of the company’s stock.
Wall Street Analysts Forecast Growth
Several analysts have issued reports on SEM shares. Mizuho reaffirmed a “neutral” rating and issued a $16.50 price objective (down from $17.00) on shares of Select Medical in a research report on Tuesday, May 12th. Benchmark downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Wednesday, March 4th. Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a $16.50 price objective (down from $19.00) on shares of Select Medical in a research report on Tuesday, March 3rd. Weiss Ratings raised shares of Select Medical from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, February 20th. Finally, Wall Street Zen downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, March 9th. One investment analyst has rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $15.50.
Select Medical Stock Up 0.0%
SEM stock opened at $16.51 on Monday. Select Medical Holdings Corporation has a twelve month low of $11.65 and a twelve month high of $16.99. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.88. The company has a market capitalization of $2.05 billion, a P/E ratio of 15.57, a PEG ratio of 0.95 and a beta of 1.02. The firm has a 50 day simple moving average of $16.35 and a 200-day simple moving average of $15.41.
Select Medical (NYSE:SEM – Get Free Report) last released its quarterly earnings results on Thursday, April 30th. The health services provider reported $0.36 earnings per share for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.07). Select Medical had a return on equity of 6.62% and a net margin of 2.42%.The company had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.41 billion. During the same period in the previous year, the business posted $0.44 EPS. The firm’s quarterly revenue was up 5.0% compared to the same quarter last year. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. On average, equities research analysts predict that Select Medical Holdings Corporation will post 1.26 earnings per share for the current fiscal year.
Select Medical Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 28th. Shareholders of record on Thursday, May 14th will be issued a $0.0625 dividend. This represents a $0.25 dividend on an annualized basis and a yield of 1.5%. The ex-dividend date of this dividend is Thursday, May 14th. Select Medical’s payout ratio is currently 23.58%.
Select Medical declared that its board has approved a share repurchase program on Thursday, February 19th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the health services provider to reacquire up to 49.5% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company’s board of directors believes its stock is undervalued.
About Select Medical
Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.
Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.
Featured Articles
- Five stocks we like better than Select Medical
- Robinhood, SoFi, and Webull Are Telling Very Different Stories
- As Broadcom Eclipses $2 Trillion, Private Credit Giants Wants In
- Target the Red-Hot Spin-Off and Merger Space With These ETFs
- Samsung Joins the $1 Trillion Club as AI Memory Demand Explodes
Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings Corporation (NYSE:SEM – Free Report).
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.
